BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25202418)

  • 1. Hyperleukocytosis: A report of five cases and review of the literature.
    Gong J; Wu B; Guo T; Zhou S; He B; Peng X
    Oncol Lett; 2014 Oct; 8(4):1825-1827. PubMed ID: 25202418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case report of therapeutic leukapheresis in an adult with chronic myelogenous leukemia presenting with hyperleukocytosis and leukostasis.
    Shafique S; Bona R; Kaplan AA
    Ther Apher Dial; 2007 Apr; 11(2):146-9. PubMed ID: 17381536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukostasis in Chronic Lymphocytic Leukemia.
    Singh N; Singh Lubana S; Dabrowski L; Sidhu G
    Am J Case Rep; 2020 Jul; 21():e924798. PubMed ID: 32616708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?
    Bewersdorf JP; Zeidan AM
    Cells; 2020 Oct; 9(10):. PubMed ID: 33080779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperleukocytosis, leukostasis and leukapheresis: practice management.
    Ganzel C; Becker J; Mintz PD; Lazarus HM; Rowe JM
    Blood Rev; 2012 May; 26(3):117-22. PubMed ID: 22364832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperleukocytosis and leukostasis: management of a medical emergency.
    Giammarco S; Chiusolo P; Piccirillo N; Di Giovanni A; Metafuni E; Laurenti L; Sica S; Pagano L
    Expert Rev Hematol; 2017 Feb; 10(2):147-154. PubMed ID: 27967252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose cyclophosphamide for cytoreduction in patients with acute myeloid leukemia with hyperleukocytosis or leukostasis.
    Zhao J; Bewersdorf JP; Jaszczur S; Kowalski A; Perreault S; Schiffer M; Gore S; Podoltsev N; Prebet T; Shallis R; Zeidan AM
    Leuk Lymphoma; 2021 May; 62(5):1195-1202. PubMed ID: 33325761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of hyperleukocytosis in 2017: Do we still need leukapheresis?
    Korkmaz S
    Transfus Apher Sci; 2018 Feb; 57(1):4-7. PubMed ID: 29477941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndrome.
    Blum W; Porcu P
    Semin Thromb Hemost; 2007 Jun; 33(4):350-4. PubMed ID: 17525892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperleukocytosis and leukostasis in acute and chronic leukemias.
    Macaron W; Sargsyan Z; Short NJ
    Leuk Lymphoma; 2022 Aug; 63(8):1780-1791. PubMed ID: 35357988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Successful induction therapy for acute myeloid leukemia complicated with brain hemorrhage and hyperleukocytosis].
    Miyazaki T; Abe N; Yamazaki E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Tachibana T; Kamijo A; Tomita N; Ishigastubo Y
    Rinsho Ketsueki; 2016 Feb; 57(2):180-5. PubMed ID: 26935637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocytapheresis for the treatment of hyperleukocytosis secondary to acute leukemia.
    Aqui N; O'Doherty U
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):457-60. PubMed ID: 25696894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukapheresis and Hyperleukocytosis, Past and Future.
    Zhang D; Zhu Y; Jin Y; Kaweme NM; Dong Y
    Int J Gen Med; 2021; 14():3457-3467. PubMed ID: 34285568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukostasis: Management to Prevent Crisis in Acute Leukemia
.
    Blackburn LM; Brown S; Munyon A; Orovets M
    Clin J Oncol Nurs; 2017 Dec; 21(6):E267-E271. PubMed ID: 29149122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Fire: Acute Blast Crisis/Hyperviscosity Syndrome.
    Emerson G; Kaide CG
    Emerg Med Clin North Am; 2018 Aug; 36(3):603-608. PubMed ID: 30037446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukostasis in adult acute hyperleukocytic leukemia: a clinician's digest.
    Ali AM; Mirrakhimov AE; Abboud CN; Cashen AF
    Hematol Oncol; 2016 Jun; 34(2):69-78. PubMed ID: 27018197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocytoreduction for acute leukemia.
    Porcu P; Farag S; Marcucci G; Cataland SR; Kennedy MS; Bissell M
    Ther Apher; 2002 Feb; 6(1):15-23. PubMed ID: 11886572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare complication of leukostasis with AML M4 patient: Microcirculatory dysfunction of upper extremities.
    Ersayoğlu İ; Yazıcı Özkaya P; Metin H; Hekimci H; Zararcı K; Yılmaz Karapınar D; Karapınar B
    Transfus Apher Sci; 2023 Aug; 62(4):103717. PubMed ID: 37173209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits.
    Shallis RM; Stahl M; Bewersdorf JP; Hendrickson JE; Zeidan AM
    Expert Rev Hematol; 2020 May; 13(5):489-499. PubMed ID: 32248712
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic Leukocytapheresis to relieve priapism due to leukostasis in CML patients: Our experience in a tertiary care centre.
    Sil S; Mohan AK; Negi G; Banerjee P; Kaur D; Mittal A; Jain A
    Transfus Clin Biol; 2024 Feb; 31(1):36-40. PubMed ID: 37944664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.